Hedge fund manager Bill Ackman first bought a $3.3 billion stake in Valeant Pharmaceuticals Intl Inc (NYSE: VRX) back in 2015 when the stock was trading north of $200 per share.
March 30, 2017 at 06:00PM
http://ift.tt/2nDnMFf
from Jayson Derrick
http://ift.tt/2nDnMFf
No comments:
Post a Comment